Updates are available Correction dated 2023-11-07
Click to view Correction: https://doi.org/10.1038/s41429-023-00671-6
-
Authors
Butler, Mark S. http://orcid.org/0000-0001-6689-4236
Henderson, Ian R. http://orcid.org/0000-0002-9954-4977
Capon, Robert J. http://orcid.org/0000-0002-8341-7754
Blaskovich, Mark A. T. http://orcid.org/0000-0001-9447-2292
- License Information
-
More Information
Article History
Received: 2 March 2023
Revised: 20 April 2023
Accepted: 25 April 2023
First Online: 8 June 2023
Change Date: 7 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41429-023-00671-6
Compliance with ethical standards
:
: MATB has conducted antibiotic research that was funded by Botanix Pharmaceuticals and has received funding from CARB-X. MATB is an inventor of patents describing novel antibiotics.
